Nature Reviews Drug Discovery 9, 628–642 (2010)
In figure 2 and figure 3, there was an error in the chemical structure of agomelatine; the amide group was omitted. The correct structure is now presented in the online html and pdf versions, and is also provided below.
Additional information
The online version of the original article can be found at 10.1038/nrd3140
Rights and permissions
About this article
Cite this article
de Bodinat, C., Guardiola-Lemaitre, B., Mocaër, E. et al. Erratum: Agomelatine, the first melatonergic antidepressant: discovery, characterization and development. Nat Rev Drug Discov 9, 743 (2010). https://doi.org/10.1038/nrd3274
Issue Date:
DOI: https://doi.org/10.1038/nrd3274
This article is cited by
-
Investigating the relationship between melatonin levels, melatonin system, microbiota composition and bipolar disorder psychopathology across the different phases of the disease
International Journal of Bipolar Disorders (2019)
-
A Meeting of Two Chronobiological Systems: Circadian Proteins Period1 and BMAL1 Modulate the Human Hair Cycle Clock
Journal of Investigative Dermatology (2014)
-
The interaction of escitalopram and R-citalopram at the human serotonin transporter investigated in the mouse
Psychopharmacology (2014)
-
Insights into the influence of 5-HT2c aminoacidic variants with the inhibitory action of serotonin inverse agonists and antagonists
Journal of Molecular Modeling (2014)
-
Effect of melatonin on depressive symptoms and anxiety in patients undergoing breast cancer surgery: a randomized, double-blind, placebo-controlled trial
Breast Cancer Research and Treatment (2014)
